S
SNDX icon

SignatureFD’s Syndax Pharmaceuticals SNDX Stock Holding History

SignatureFD’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219 Buy
+10
New +$208 ﹤0.01% 3411
2025
Q3 		– Sell
-73
Closed -$684 – 3471
2025
Q2 		$684 Sell
73
-1,321
-95% -$14.5K ﹤0.01% 3067
2025
Q1 		$17.1K Sell
1,394
-684
-33% -$9.65K ﹤0.01% 2138
2024
Q4 		$27.5K Sell
2,078
-1,745
-46% -$29.9K ﹤0.01% 1900
2024
Q3 		$73.6K Buy
3,823
+89
+2% +$1.84K ﹤0.01% 1378
2024
Q2 		$76.7K Sell
3,734
-190
-5% -$3.98K ﹤0.01% 1296
2024
Q1 		$93.4K Buy
3,924
+176
+5% +$3.92K ﹤0.01% 1231
2023
Q4 		$81K Buy
3,748
+3,622
+2,875% +$55.7K ﹤0.01% 1222
2023
Q3 		$1.83K Sell
126
-23
-15% -$435 ﹤0.01% 2795
2023
Q2 		$3.12K Sell
149
-57
-28% -$1.19K ﹤0.01% 2660
2023
Q1 		$4.35K Buy
206
+136
+194% +$3.38K ﹤0.01% 2563
2022
Q4 		$1.78K Hold
70
– – ﹤0.01% 2846
2022
Q3 		$2K Hold
70
– – ﹤0.01% 2844
2022
Q2 		$1K Buy
70
+18
+35% +$300 ﹤0.01% 3008
2022
Q1 		$1K Buy
+52
New +$876 ﹤0.01% 3060
2021
Q4 		– Sell
-42
Closed -$1K – 3261
2021
Q3 		$1K Buy
+42
New +$700 ﹤0.01% 2921

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

SignatureFD's SNDX Position: Q2 2026 in Review

SignatureFD opened a new position in Syndax Pharmaceuticals (SNDX) in Q2 2026: 10 shares worth $219. The stake represents ﹤0.01% of the portfolio and ranks #3411 among its holdings. This is a return to the name: SignatureFD previously reported a position in SNDX as recently as Q2 2025.

SignatureFD first reported a position in SNDX in Q3 2021 and has held it in 16 quarters since. The position peaked at $93.4K in Q1 2024. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • SignatureFD held 10 shares of Syndax Pharmaceuticals worth $219 as of Q2 2026.
  • Syndax Pharmaceuticals was a new SignatureFD position in Q2 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3411 holding.
  • SignatureFD first reported a position in Syndax Pharmaceuticals in Q3 2021 and has held it in 16 quarters since.
  • SignatureFD's Syndax Pharmaceuticals position peaked at $93.4K in Q1 2024.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.